Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

High-throughput screening in colorectal cancer tissue-originated spheroids.

Jumpei Kondo | Tomoya Ekawa | Hiroko Endo | Kanami Yamazaki | Norio Tanaka | Yoji Kukita | Hiroaki Okuyama | Jiro Okami | Fumio Imamura | Masayuki Ohue | Kikuya Kato | Taisei Nomura | Arihiro Kohara | Seiichi Mori | Shingo Dan | Masahiro Inoue
Cancer science | 2019

Patient-derived cancer organoid culture is an important live material that reflects clinical heterogeneity. However, the limited amount of organoids available for each case as well as the considerable amount of time and cost to expand in vitro makes it impractical to perform high-throughput drug screening using organoid cultures from multiple patients. Here, we report an advanced system for the high-throughput screening of 2427 drugs using the cancer tissue-originated spheroid (CTOS) method. In this system, we apply the CTOS method in an ex vivo platform from xenograft tumors, using machines to handle CTOS and reagents, and testing a CTOS reference panel of multiple CTOS lines for the hit drugs. CTOS passages in xenograft tumors resulted in minimal changes of morphological and genomic status, and xenograft tumor generation efficiently expanded the number of CTOS to evaluate multiple drugs. Our panel of colorectal cancer CTOS lines exhibited diverse sensitivities to the hit compounds, demonstrating the usefulness of this system for investigating highly heterogeneous disease.

Pubmed ID: 30343529

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


SomaticIndelDetector (tool)

RRID:SCR_005107

Tool for calling indels in Tumor-Normal paired sample mode.

View all literature mentions

VARSCAN (tool)

RRID:SCR_006849

A platform-independent, technology-independent software tool for identifying SNPs and indels in massively parallel sequencing of individual and pooled samples. Given data for a single sample, VarScan identifies and filters germline variants based on read counts, base quality, and allele frequency. Given data for a tumor-normal pair, VarScan also determines the somatic status of each variant (Germline, Somatic, or LOH) by comparing read counts between samples. (entry from Genetic Analysis Software)

View all literature mentions

TreeView (tool)

RRID:SCR_013503

Software to graphically browse results of clustering and other analyses from Cluster.

View all literature mentions